Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

CombiGene AB (COJ0) AI Stock Analysis

0 Followers
DE:COJ0

CombiGene AB

(Frankfurt:COJ0)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Debt-Free Balance SheetA debt-free structure and substantial equity base reduce financial risk and provide resilience while the company advances its programs. This capital position can preserve strategic flexibility and limit financing pressure during continued research and development investment.
Negative Factors
Persistent Cash BurnPersistent negative operating and free cash flow means the business is not yet self-funding its activities. Continued cash consumption can require additional capital or transactions to sustain development, reducing flexibility even though the balance sheet currently carries no debt.

CombiGene AB (COJ0) vs. iShares MSCI Germany ETF (EWG)

-10%-5%0%5%10%15%DE:COJ00.00%EWG+6.88%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 4.11M
Dividend Yield
88.89%
Average Volume (3M)
―
Price to Earnings (P/E)
38.8
Beta (1Y)
0.43
Revenue Growth
―
EPS Growth
―
Country
Germany
Employees
1
Sector
Financial
Sector Strength
68
Industry
Asset Management

CombiGene AB Business Overview & Revenue Model

Company Description

Lärkberget AB (publ) functions as an investment firm, engaging in a variety of financial endeavors. Its operations encompass direct capital deployment into low-risk instruments, broader financial investments, acquiring stakes in privately held yet pr...

CombiGene AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

DE:COJ0 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
SE:EQTSE:EQT59NeutralSEK 395.35B32.86―1.47%-18.18%20.49%
SE:ATINSE:ATIN38UnderperformSEK 289.46M-5.32――-33.93%-9.82%

* Financial Sector Average

Performance Comparison

-20%0%20%DE:COJ0SE:ATINSE:EQTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:COJ0 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:COJ0CombiGene AB0.160.000.00%
SE:ATINAthanase Innovation AB15.00-1.80-10.71%
SE:EQTEQT AB316.80-13.28-4.02%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.